SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-017556
Filing Date
2018-12-17
Accepted
2018-12-14 18:02:58
Documents
11
Period of Report
2018-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 33756
2 ex1-1.htm EX-1.1 381452
3 ex5-1.htm EX-5.1 34283
4 ex99-1.htm EX-99.1 14849
5 ex99-2.htm EX-99.2 14980
6 ex5-1_001.jpg GRAPHIC 3113
7 ex5-1_002.jpg GRAPHIC 5323
8 ex99-1_001.jpg GRAPHIC 3716
9 ex99-1_002.jpg GRAPHIC 3716
10 ex99-2_001.jpg GRAPHIC 3716
11 ex99-2_002.jpg GRAPHIC 3716
  Complete submission text file 0001493152-18-017556.txt   513552
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 181236566
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1